Entasis Therapeutics, created in 2015 (United States), from 2214 competing brands. Entasis Therapeutics is owned by Entasis Therapeutics Holdings Inc., listed on the stock exchange of New York Entasis Therapeutics is part of the Biotechnology activity sector.